Medifast Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	346.1	385.79	602.46	1,072	1,599	1,526
Revenue Growth (YoY)	-36.31%	-35.97%	-43.80%	-32.94%	4.75%	63.25%
Cost of Revenue	103.41	110.6	157.84	296.2	458.16	398.49
Gross Profit	242.7	275.19	444.62	775.85	1,140	1,128
Selling, General & Admin	258.94	289.4	441.75	649.45	955.61	911.36
Total Operating Expenses	258.94	289.4	441.75	649.45	955.61	911.36
Operating Income	-16.25	-14.21	2.88	126.4	184.81	216.24
Interest Income	5.59	5.52	4.8	2.49	-0.7	-0.23
Other Non-Operating Income (Expense)	2.55	3.06	-3.9	-0.1	0.05	0.12
Total Non-Operating Income (Expense)	8.14	8.57	0.91	2.4	-0.66	-0.11
Pretax Income	-8.11	-5.64	3.79	128.8	184.06	216.13
Provision for Income Taxes	11.92	13.03	1.7	29.38	40.49	52.1
Net Income	-20.02	-18.67	2.09	99.42	143.57	164.03
Net Income to Common	-20.02	-18.67	2.09	99.42	143.57	164.03
Net Income Growth	-	-	-97.90%	-30.75%	-12.47%	59.47%
Shares Outstanding (Basic)	11	11	11	11	11	12
Shares Outstanding (Diluted)	11	11	11	11	11	12
Shares Change (YoY)	0.48%	0.16%	0.39%	-3.15%	-4.55%	-0.31%
EPS (Basic)	-1.82	-1.70	0.19	9.13	12.82	14.01
EPS (Diluted)	-1.83	-1.70	0.19	9.10	12.73	13.89
EPS Growth	-	-	-97.91%	-28.52%	-8.35%	60.02%
Shares Outstanding	11.12	10.99	10.94	10.9	10.87	11.59
Free Cash Flow	-1.47	1.25	17.02	141.17	177.89	60.34
Free Cash Flow Growth	-	-92.66%	-87.94%	-20.64%	194.83%	-56.69%
Free Cash Flow Per Share	-0.13	0.11	1.55	12.93	15.78	5.11
Dividends Per Share	-	-	-	4.950	6.560	5.680
Dividend Growth	-	-	-	-24.54%	15.49%	25.66%
Gross Margin	70.12%	71.33%	73.80%	72.37%	71.34%	73.89%
Operating Margin	-4.69%	-3.68%	0.48%	11.79%	11.56%	14.17%
Profit Margin	-5.78%	-4.84%	0.35%	9.27%	8.98%	10.75%
FCF Margin	-0.43%	0.32%	2.83%	13.17%	11.13%	3.95%
EBITDA	-1.8	0.03	15.59	139.51	195.79	223.05
EBITDA Margin	-0.52%	0.01%	2.59%	13.01%	12.25%	14.62%
EBIT	-16.25	-14.21	2.88	126.4	184.81	216.24
EBIT Margin	-4.69%	-3.68%	0.48%	11.79%	11.56%	14.17%
Effective Tax Rate	-147.03%	-231.12%	44.78%	22.81%	22.00%	24.10%

SEC Filings: 10-K · 10-Q